Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304 (Q28376523)

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

The Maudsley Reactive and Nonreactive strains of rats: A survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Neuropeptide Y and sigma ligand (JO 1784) act through a Gi protein to block the psychological stress and corticotropin-releasing factor-induced colonic motor activation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Stimulus and response factors affecting the development of behavioral sensitization to apomorphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Apomorphine-induced aggressiveness and [3H]citalopram binding after antidepressant treatment in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Neuropeptide Y-like immunoreactivity in schizophrenia. Relationships with clinical measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Rats bred for enhanced apomorphine susceptibility have elevated tyrosine hydroxylase mRNA and dopamine D2-receptor binding sites in nigrostriatal and tuberoinfundibular dopamine systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

The use of various animal models in the study of stress and stress-related phenomena.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Amphetamine-induced changes in immunoreactive NPY in rat brain, pineal gland and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Central nervous system pharmacology of neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9

Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900199-9